GlassScriptPhysician profile
Michael Venincasa
NPI 1811456833
$7,058.98
in general payments reported to CMS, 2019-2025
23 companies · $2,948 in 2025
The $2,948 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $296 · 2022: $147 · 2023: $1,008 · 2024: $2,659 · 2025: $2,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,398 · Entertainment: $215 · Education: $2.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,397.69 |
| Entertainment | $214.84 |
| Education | $2.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,550.18 | 2021-2025 | Clareon, Simbrinza, Argos |
| Tarsus Pharmaceuticals, INC. | $660.56 | 2024-2025 | Xdemvy |
| Abbvie INC. | $571.39 | 2023-2025 | Durysta |
| Sun Pharmaceutical Industries INC. | $475.64 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $458.09 | 2023-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $392.47 | 2023-2025 | Miebo, Xiidra, Envista Envy Iol |
| Mallinckrodt Hospital Products INC. | $351.38 | 2023-2025 | Acthar |
| Optos, INC. | $214.84 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Harrow Eye, LLC | $199.89 | 2024-2025 | Vevye |
| Biotissue Holdings INC. | $187.54 | 2023-2024 | |
| Dompe US, INC. | $166.31 | 2024-2025 | Oxervate |
| Rxsight INC | $154.92 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Amgen INC. | $145.81 | 2024 | Tepezza |
| New World Medical,INC. | $141.18 | 2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Astellas Pharma US INC | $121.83 | 2025 | Izervay |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $92.96 | 2024-2025 | Iyuzeh |
| Carl Zeiss Meditec USA, INC. | $49.93 | 2024 | Cirrus Hd-Oct |
| Glaukos Corporation | $31.58 | 2025 | Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $26.14 | 2025 | Tecnis Iol |
| Apellis Pharmaceuticals, INC. | $19.57 | 2024 | Syfovre |
| Rayner Intraocular Lenses Limited | $18.98 | 2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Sight Sciences, INC. | $17.98 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Lensar, INC. | $9.81 | 2025 | Lensar Laser System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Venincasa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.